Cephalon Inc., of Frazer, Pa., reported second quarter net sales of $730.1 million, a 2 percent increase over the second quarter of 2010, including $332.3 million for its central nervous system franchise, $140.6 million for its pain franchise and $158.8 million for its oncology franchise.